Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07176325 · ClinicalTrials.gov registry record
Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation
A clinical trial of Side Effects of Creatine Monohydrate Dosing, sponsored by Vireo Systems.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT07176325 is a study of Side Effects of Creatine Monohydrate Dosing that has completed, run by Vireo Systems. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07176325, a study of Side Effects of Creatine Monohydrate Dosing, has completed, sponsored by Vireo Systems.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aimed to investigate the incidence and severity of GI symptoms associated with daily CM supplementation, with and without a loading phase, in healthy male and female adults.
Conditions Studied
Interventions
- OTHER Creatine Monohydrate
Study Locations (1)
New Jersey
- Princeton Consumer Research - Raritan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2024-07-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07176325
The ClinicalTrials.gov registry entry for NCT07176325 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vireo Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Side Effects of Creatine Monohydrate Dosing appearing as the primary indexed condition, and to 1 intervention - of which Creatine Monohydrate is the first listed.
NCT07176325 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07176325 about?
NCT07176325 is a clinical study titled "Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation". This study aimed to investigate the incidence and severity of GI symptoms associated with daily CM supplementation, with and without a loading phase, in healthy male and female adults.
What is the current status of trial NCT07176325?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2024-05-30. Estimated completion is 2024-07-03.
What conditions does trial NCT07176325 study?
This clinical trial studies the following conditions: Side Effects of Creatine Monohydrate Dosing.
What interventions are being tested in trial NCT07176325?
The interventions under investigation include: Creatine Monohydrate (OTHER).
Who is sponsoring clinical trial NCT07176325?
This trial is sponsored by Vireo Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07176325 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.